Protagonist Therapeutics shares are trading lower. The company reported Q2 financial results.
Portfolio Pulse from Benzinga Newsdesk
Protagonist Therapeutics shares are trading lower following the company's Q2 financial results.
August 06, 2024 | 11:50 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Protagonist Therapeutics shares are trading lower after the company reported its Q2 financial results.
The decline in Protagonist Therapeutics' share price is directly linked to the market's reaction to their Q2 financial results. Investors likely found the results disappointing, leading to a sell-off.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100